HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)
2,805.00
+85.00 (3.13%)
At close: Feb 27, 2026
-71.55% (1Y)
| Market Cap | 235.50B -75.5% |
| Revenue (ttm) | 63.25B +16.8% |
| Net Income | -7.99B |
| EPS | -95.29 |
| Shares Out | 83.96M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 640,636 |
| Average Volume | 529,594 |
| Open | 2,795.00 |
| Previous Close | 2,720.00 |
| Day's Range | 2,765.00 - 2,920.00 |
| 52-Week Range | 2,690.00 - 11,090.00 |
| Beta | -0.86 |
| RSI | 40.64 |
| Earnings Date | Feb 20, 2026 |